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monitor for quality assurance purposes. The ability of the IQM 
to detect additional error modes needs further investigation. 
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Purpose or Objective: The iQM® monitor system was tested 
to provide a method for treatment field verification using an 
independent monitor system mounted below the gantry. 
Real-time monitoring allows delivery errors to be detected 
during treatment, including record & verify mismatch, 
calibration errors or malfunctions in multi-leaf collimator 
(MLC), increasing patient safety. 
 
Material and Methods: The iQM® system consists of a large 
area ion-chamber with a spatial gradient. The ionization 
chamber and the data acquisition software system were 
interfaced to an Elekta Synergy accelerator. During 6 months 
of VMAT quality assurance (QA) sessions, more than 70 
sessions of measurements were carried out to validate the 
repeatability of the detector as a dedicated QA instrument. 
To evaluate efficiency in clinical practice, a dummy plan and 
a Head and Neck (H&N) VMAT plan were delivered and 
investigated using the system. The dummy plan was 
composed of 18 segments (17 segments 4x4 cm2 and 1 
segment 10x10 cm2) and was delivered more than 100 times 
with constant 50 MU per segments. The VMAT plan was 
composed of 140 control points delivered by an arc, with low 
gantry speed, high MU and low dose rate. The sensitivity was 
then tested by introducing specific dosimetric increases of 
MU (1%,2%,3%,4%,5%,10% and 20%) in the H&N plan 
(VMATError Plan). Rotational analysis and validation were 
investigated; correlation with gantry and collimator angles 
was quantified using SPSS ANOVA analysis. 
 
Results: The dummy plan delivered in standard condition 
(gantry and collimator angles=0°) revealed a mean variation 
in signal counts of 0.7±1.0% compared with the 
commissioning day. Independence of the detector with gantry 
position were investigated (gantry angle: 0°-90°-180°-270° 
and collimator angle: 0°-45°-135°-225°-315°). No statistical 
difference (significance ≈ 1) was detected for all segments, 
confirming the high quality of the instrument for daily QA. In 
the H&N plan, a decrease in measured counts was observed 
in the particular range of gantry angles from 120° through 
240°. Statistical analysis showed a mean dose discrepancy of 
2.8±1.0% between planned and measured errors from the 
original plan. For the VMATError Plan, the system is capable 
of detecting the error introduced with an agreement of 
0.2±0.5% (R2=0.99). No correlation related to collimator 
angle and delivered MU was detected.  
 
 
 
 
 
 
Conclusion: The system was shown to be stable for daily QA 
and could add many advantages to the patients’ safety during 
treatment. Taking into account all the treatment factors, the 
detector provides punctual and cumulative output for each 
beam segment, which is compared in real time to each 
segment’s expected value. The robustness of the 
measurement results suggests that the system could 
recognize errors or inadequate MU during the delivery. The 
significant signal deviation seen at particular gantry rotations 
could be investigated in order to improve the results 
obtained. 
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Purpose or Objective: Machine Performance Check (MPC) is 
a tool provided with Varian TrueBeam linear accelerators to 
verify, prior to treatment, that critical functions of the 
system are within the established tolerances. An evaluation 
carried out by Clivio et al. compared the results of the 
checks they made using the MPC application and their 
independent measurements. The purpose of this analysis is to 
compare the result obtained with the MPC tool at our 
institution with those acquired in the mentioned study. 
 
Material and Methods: In order to perform the MPC checks, 
the IsoCal phantom has to be mounted to the couch top using 
an appropriate holder. The system acquires a series of MV 
and kV images and analyses them in order to obtain values 
for different parameters. Two distinct types of checks can be 
carried out with MPC: beam constancy checks and geometry 
checks. With the first ones beam output, uniformity and 
center shift can be evaluated. Geometry checks give us 
information about isocenter’s size, imaging devices 
positioning, gantry, MLC, collimator, jaws and couch 
positioning. We analyzed the data obtained over 15 weeks of 
measurements in a TrueBeamSTx 2.0 with a Millenium 
HD120MLC and a DMI imager. Beam checks were done for all 
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the available photon energies in our TrueBeam: 6MV, 15MV, 
6MV FFF and 10MV FFF. Geometrical checks were measured 
only for the 6MV beam. 
 
Results: In all our measurements we found that the results 
were within the established tolerances. The value of the 
isocenter’s size is, in our case, 0.27 mm, very close to that 
obtained by Clivio et al. for the same energy, 0.34 mm. The 
values of the 6MV beam center shift, MV imager projection 
offset and absolute gantry positioning are the same that the 
ones obtained in the mentioned study: 0.04 mm, 0.17 mm 
and -0.09° respectively. For that same energy the offset of 
the collimator rotation is, in our case, 0.15°, while the one 
reported in the study is 0.17°, and the kV imager projection 
offset, 0.24 mm versus 0.32 mm. The output change in our 
TrueBeam varies from -0.58% for the 10MV FFF beam to -
0.50% for the 6MV beam. In the study these values range from 
0.06% for their 15 MV beam to 0.24% for their 6MV FFF beam. 
 
Conclusion: Our TrueBeam MPC results were compared with 
those obtained by Clivio et al. at their institution. They show 
great agreement with those reported in their study. We have 
established MPC tool measurements as part of our routine 
daily QA. 
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Purpose or Objective: To evaluate the dosimetric and 
optimization algorithm accuracy of a newly released version 
13.5 of the Eclipse treatment planning system (TPS) prior to 
upgrade, utilizing the recently published AAPM Medical 
Physics Practice Guideline (MPPG), “Commissioning and QA of 
treatment planning dose calculations”. 
 
Material and Method: Eclipse V13.5 includes many novel 
features, such as contouring tool enhancements, streamlined 
4D CT contouring, new physical materials for the AcurosXB 
(AXB) dose algorithm, and faster optimization engines. MPPG 
phantom tests were performed to validate both static and 
dynamic beams in both homo- and hetero- generous material. 
Additionally, 54 patient plans were re-calculated in V13.5 
with the same beam parameters, monitor units, and dose 
algorithms in order to examine algorithm difference. A dose-
difference plan was created by subtracting the dose 
calculated in V13.5 from V11 and evaluated in 3D dose 
display. Those re-calculated patient plans included a variety 
of treatment sites, energies, and techniques. However, the 
new Photon Optimizer (PO) algorithm was developed in V13.5 
to replace the previous Dose Volume Optimizer (DVO) in IMRT 
and Progressive Resolution Optimizer (PRO) in VMAT. In order 
to compare the PO and DVO/PRO optimizers, 25 IMRT/VMAT 
clinical plans were re-optimized with PO using the same 
objectives, prescriptions, and number of iterations. The plan 
quality and optimization time were examined. 
 
Results: Dose differences for all clinical cases and MPPG 
phantom tests in-field and in homogeneous areas, were 
within 1% and 3% for photon and electron plans, respectively. 
Although the beam models were not re-commissioned in 
V13.5, the dosimetric leaf gap (DLG) value was modified and 
the new physical material was added in AXB; as a result the 
dose differences correspond to differences in the dose 
algorithms. Therefore, at field edges and heterogeneity 
interfaces, maximum dose differences increased to 3% and 6% 
for photons and electrons, respectively. Dose calculated 
using AXB was found to be 3% less at the lung interface and 
inside the lung in V13.5 compared to dose calculated in V11, 
but no dose difference calculated using AAA was seen. PO 
could optimize plans 20-30% faster than DVO/PRO. For most 
cases, no significant difference in plan quality was noted. 
However, lung SBRT cases with PO showed a reduction in MUs 
and slightly improved dose conformity. 
 
 
 
 
Conclusion: Commissioning and QA of new TPS version is 
essential prior to clinical release. The tests suggested by 
MPPG provide an excellent framework for this work, 
particularly when combined with additional clinical cases. 
Dose differences noted were chiefly located at beam edges, 
possibly due to modified DLG values, and in heterogeneous 
materials and interfaces using AXB, potentially due to 
differences in material specification. The PO improved 
optimization efficiency in all cases and MU economy and dose 
conformity in some SBRTs, with no reduction in plan quality. 
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